abstract |
Provided herein are embodiments relating to therapeutic applications of molecules that modulate the biological activity of LILRA3. In some embodiments, the molecules bind TIM-3. In some embodiments, modulation of the interaction of TIM-3 and LILRA3 stimulates the release of pro-inflammatory cytokines; e.g., myeloid-associated pro -inflammatory cytokines. |